N/A
Completed N=198
Group Treatment for PTSD: A Randomized Clinical Trial With Veterans
Source: ClinicalTrials.gov NCT01544088 ↗Enrolled (actual)
198
Serious AEs
18.7%
Results posted
Apr 2019
Primary outcomePrimary: Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) — 28.76; 31.87 units on a scale
Summary
The purpose of this study is to examine whether group cognitive behavioral treatment (GCBT) is efficacious in the treatment of PTSD in a sample of male Veterans. Veterans with a primary diagnosis of chronic PTSD will be randomly assigned to either GCBT or a supportive group treatment condition. Both treatments will consist of 14, weekly sessions. Assessment of PTSD and related symptoms will be conducted at pre-treatment, mid treatment, post-treatment, and 3-, 6-, - and 12-month follow-up.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) |
28.76; 31.87 | — |
| SECONDARY Beck Depression Inventory, II (BDI-II) |
18.95; 22.29 | — |
| SECONDARY Short-Form Health Survey (SF-36) |
55.00; 59.05 | — |
| SECONDARY Beck Anxiety Inventory (BAI) |
15.23; 18.67 | — |
Eligibility Criteria
Inclusion Criteria
- primary diagnosis of DSM-IV (American Psychiatric Association, 2000) criteria for chronic, PTSD (symptoms lasting 3 months or more)
- male, Veteran
- be free of psychosis and impaired cognitive function caused by traumatic brain injury or dementia
Exclusion Criteria
- a current diagnosis of substance dependence or unstable bipolar disorder
- currently involved in psychosocial treatment for PTSD
Data sourced from ClinicalTrials.gov (NCT01544088). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.